These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1878756)
1. Short-term effects of administration of anticonvulsant drugs on free carnitine and acylcarnitine in mouse serum and tissues. Camiña MF; Rozas I; Gómez M; Paz JM; Alonso C; Rodriguez-Segade S Br J Pharmacol; 1991 May; 103(1):1179-83. PubMed ID: 1878756 [TBL] [Abstract][Full Text] [Related]
2. Alteration of renal carnitine metabolism by anticonvulsant treatment. Camiña MF; Rozas I; Castro-Gago M; Paz JM; Alonso C; Rodriguez-Segade S Neurology; 1991 Sep; 41(9):1444-8. PubMed ID: 1891096 [TBL] [Abstract][Full Text] [Related]
3. Effects of acute valproate administration on carnitine metabolism in mouse serum and tissues. Rozas I; Camiña MF; Paz JM; Alonso C; Castro-Gago M; Rodriguez-Segade S Biochem Pharmacol; 1990 Jan; 39(1):181-5. PubMed ID: 2105093 [TBL] [Abstract][Full Text] [Related]
4. Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Zolkowska D; Andres-Mach M; Prisinzano TE; Baumann MH; Luszczki JJ Psychopharmacology (Berl); 2015 Jul; 232(14):2463-79. PubMed ID: 25697861 [TBL] [Abstract][Full Text] [Related]
5. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients. Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476 [TBL] [Abstract][Full Text] [Related]
6. Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study. Moreno FA; Macey H; Schreiber B J Clin Psychiatry; 2005 May; 66(5):555-8. PubMed ID: 15986510 [TBL] [Abstract][Full Text] [Related]
7. Carnitine metabolism in valproate-treated rats: the effect of L-carnitine supplementation. Nishida N; Sugimoto T; Araki A; Woo M; Sakane Y; Kobayashi Y Pediatr Res; 1987 Nov; 22(5):500-3. PubMed ID: 3120144 [TBL] [Abstract][Full Text] [Related]
8. 1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model. Luszczki JJ; Antkiewicz-Michaluk L; Czuczwar SJ Neuropharmacology; 2006 Feb; 50(2):133-42. PubMed ID: 16153667 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients]. Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630 [TBL] [Abstract][Full Text] [Related]
10. Effects of anticonvulsants and gamma-aminobutyric acid (GABA)-mimetic drugs on immunoreactive somatostatin and GABA contents in the rat brain. Nagaki S; Kato N; Minatogawa Y; Higuchi T Life Sci; 1990; 46(22):1587-95. PubMed ID: 1972258 [TBL] [Abstract][Full Text] [Related]
11. Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in children. Hug G; McGraw CA; Bates SR; Landrigan EA J Pediatr; 1991 Nov; 119(5):799-802. PubMed ID: 1941389 [TBL] [Abstract][Full Text] [Related]
12. Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Luszczki JJ; Cioczek JD; Kocharov SL; Andres-Mach M; Kominek M; Zolkowska D Eur J Pharmacol; 2010 Dec; 648(1-3):74-9. PubMed ID: 20826140 [TBL] [Abstract][Full Text] [Related]
14. Alterations in the carnitine metabolism in epileptic children treated with valproic acid. Chung S; Choi J; Hyun T; Rha Y; Bae C J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096 [TBL] [Abstract][Full Text] [Related]
15. Evaluation ofserum free carnitine/acylcarnitine levels and left ventricular systolic functions in children with idiopathic epilepsy receiving valproic acid. Kulhas Celik I; Tasdemir HA; Ince H; Celik H; Sungur M Clin Neurol Neurosurg; 2018 Jul; 170():106-112. PubMed ID: 29772401 [TBL] [Abstract][Full Text] [Related]
16. Effect of acetazolamide on the anticonvulsant potency of several antiepileptic drugs in mice. Sato J; Nioka M; Owada E; Ito K; Murata T J Pharmacobiodyn; 1983 May; 6(5):295-300. PubMed ID: 6137528 [TBL] [Abstract][Full Text] [Related]
17. Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS. Silva MF; Selhorst J; Overmars H; van Gennip AH; Maya M; Wanders RJ; de Almeida IT; Duran M Clin Biochem; 2001 Nov; 34(8):635-8. PubMed ID: 11849623 [TBL] [Abstract][Full Text] [Related]
18. Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder. Yokoyama S; Yasui-Furukori N; Nakagami T; Miyazaki K; Ishioka M; Tarakita N; Kubo K; Sugawara N; Shimoda K Ther Drug Monit; 2020 Oct; 42(5):766-770. PubMed ID: 32482992 [TBL] [Abstract][Full Text] [Related]
19. Reduction in blood free carnitine levels in association with changes in sodium valproate (VPA) disposition in epileptic patients treated with VPA and other anti-epileptic drugs. Hiraoka A; Arato T; Tominaga I Biol Pharm Bull; 1997 Jan; 20(1):91-3. PubMed ID: 9013816 [TBL] [Abstract][Full Text] [Related]
20. Carnitine disposition before and during valproate therapy in patients with epilepsy. Riva R; Albani F; Gobbi G; Santucci M; Baruzzi A Epilepsia; 1993; 34(1):184-7. PubMed ID: 8422857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]